Assenagon Asset Management S.A. Has $1.07 Million Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Assenagon Asset Management S.A. decreased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 73.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,440 shares of the company's stock after selling 34,491 shares during the period. Assenagon Asset Management S.A.'s holdings in Prestige Consumer Healthcare were worth $1,069,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Kestra Investment Management LLC acquired a new position in shares of Prestige Consumer Healthcare during the 4th quarter valued at $27,000. CIBC Private Wealth Group LLC grew its holdings in Prestige Consumer Healthcare by 48.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after acquiring an additional 152 shares during the period. Headlands Technologies LLC acquired a new position in Prestige Consumer Healthcare during the fourth quarter worth about $40,000. McIlrath & Eck LLC raised its position in Prestige Consumer Healthcare by 19.1% in the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock worth $75,000 after acquiring an additional 154 shares in the last quarter. Finally, Johnson Financial Group Inc. acquired a new stake in Prestige Consumer Healthcare in the 4th quarter valued at about $93,000. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

PBH has been the topic of several recent research reports. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, May 17th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Trading Down 0.3%

NYSE PBH traded down $0.27 on Friday, hitting $83.37. 362,361 shares of the company were exchanged, compared to its average volume of 298,971. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82. Prestige Consumer Healthcare Inc. has a twelve month low of $64.94 and a twelve month high of $90.04. The firm has a market capitalization of $4.12 billion, a P/E ratio of 19.43, a price-to-earnings-growth ratio of 2.50 and a beta of 0.45. The company's 50 day moving average price is $83.93 and its 200-day moving average price is $82.51.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The company had revenue of $296.52 million during the quarter, compared to analysts' expectations of $289.36 million. During the same period last year, the company posted $1.02 earnings per share. The business's revenue for the quarter was up 7.0% on a year-over-year basis. Analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.